COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 50: Line 50:
*Muhammad Adnan Haider
*Muhammad Adnan Haider
*[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]]
*[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]]
*[[User:Harmeetkharoud91|Harmeet Kharoud]]
*[[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]]





Revision as of 19:32, 10 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

Cardiovascular Disorders of COVID-19 Team Members


Dermatologic Disorders of COVID-19 Team Members

  • Nuha Shah
  • Hannah Abude

Frequently Asked Inpatient Questions

Frequently Asked Outpatient Questions

Hematologic disorders of COVID-19 Team Members


Nephrologic Disorders of COVID-19 Team Members


Neurologic Disorders and COVID-19 Team Members


Ongoing Clinical Trials of COVID-19 Team Members


Pulmonary Disorders and COVID-19 Team Members

  • Rana Aljebzi
  • Ayesha Farheen Javid

Radiologic Manifestations of COVID-19 Team Members
Other Team Members